Home > National Drug Code (NDC) > Triamterene and Hydrochlorothiazide

Triamterene and Hydrochlorothiazide - 0378-2537-10 - (triamterene and hydrochlorothiazide)

Alphabetical Index


Drug Information of Triamterene and Hydrochlorothiazide

Product NDC: 0378-2537
Proprietary Name: Triamterene and Hydrochlorothiazide
Non Proprietary Name: triamterene and hydrochlorothiazide
Active Ingredient(s): 25; 37.5    mg/1; mg/1 & nbsp;   triamterene and hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Triamterene and Hydrochlorothiazide

Product NDC: 0378-2537
Labeler Name: Mylan Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA074701
Marketing Category: ANDA
Start Marketing Date: 20110504

Package Information of Triamterene and Hydrochlorothiazide

Package NDC: 0378-2537-10
Package Description: 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-2537-10)

NDC Information of Triamterene and Hydrochlorothiazide

NDC Code 0378-2537-10
Proprietary Name Triamterene and Hydrochlorothiazide
Package Description 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-2537-10)
Product NDC 0378-2537
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name triamterene and hydrochlorothiazide
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20110504
Marketing Category Name ANDA
Labeler Name Mylan Pharmaceuticals Inc.
Substance Name HYDROCHLOROTHIAZIDE; TRIAMTERENE
Strength Number 25; 37.5
Strength Unit mg/1; mg/1
Pharmaceutical Classes Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC]

Complete Information of Triamterene and Hydrochlorothiazide


General Information